Blog > Investment Research > The TFN Complete Guide to Stem Cell Companies Part 2: Share prices between $10 and $50
Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

The TFN Complete Guide to Stem Cell Companies Part 2: Share prices between $10 and $50

Today's Financial News - Posted November 21, 2008

Baltimore — (TFN): This is a Part 2 of The TFN Complete Guide to Stem Cell Companies.

The following prices are as of September 21, 2009.

$20-$50

Abbott Laboratories: (NYSE:ABT)
Market Cap: $71.96 billion
Abbott Laboratories develops, manufactures and sells a diversified line of healthcare products in four segments: Pharmaceutical, Diagnostic, Nutritional and Vascular.
Stock price: $46.55
http://www.abbott.com

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
Market Cap: $4.10 billion
Alexion Pharmaceuticals, Inc. develops biologic therapeutic products for the treatment of hematologic and neurologic diseases, cancer and autoimmune disorders.
Stock price: $46.60
http://www.alexionpharm.com/

AstraZeneca Plc (NYSE:AZN)
Market Cap: $65.86 billion
AstraZeneca Plc develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection.
Stock price: $45.46
http://www.astrazeneca.com/

Biogen Idec Inc. (NASDAQ:BIIB)
Market Cap: $14.72 billion
Biogen Idec Inc. develops, manufactures, and commercializes therapies to address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis.
Stock price: $50.97
http://www.biogenidec.com

Covance Inc. (NYSE:CVD)
Market Cap: $3.51 billion
Covance Inc.provides a range of early-stage and late-stage product development services to the biopharmaceutical and medical device industries. The company also provides laboratory testing services to the chemical, agrochemical and food industries.
Stock price: $54.85
http://www.covance.com/

Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Market Cap: $1.00 billion
Integra LifeSciences Holdings Corporation develops, manufactures and markets surgical implants for neurosurgery, spinal surgery, reconstructive surgery, as well as medical surgical equipment.
Stock price: $35.24
http://www.integra-ls.com

Intercytex Group Plc (LON:ICX)
Market Cap: $4.01 million
Intercytex Group Plc develops and commercializes cell-based therapies for the repair and regeneration of skin and hair.
Stock price: $4.12
http://www.intercytex.com/

Invitrogen Corporation (NASDAQ:IVGN)
Market Cap: $8.51 billion
Invitrogen Corporation develops, manufactures and markets research tools to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products. The company is also a supplier of sera, cell and tissue culture media and reagents, as well as in processes to grow cells in the laboratory.
Stock price: $48.27
http://www.invitrogen.com

Merck & Co., Inc. (NYSE:MRK)
Market Cap: $66.94 billion
Merck & Co., Inc. develops, manufactures and markets a range of products to improve human and animal health. The company is made up of two business segments: Pharmaceutical and Vaccines.
Stock price: $31.74
http://www.merck.com/

NuVasive, Inc. (NASDAQ:NUVA)
Market Cap: $1.54 billion
NuVasive, Inc. is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.
Stock price: $40.81
http://www.nuvasive.com/

Sigma-Aldrich Corporation (NASDAQ:SIAL)
Market Cap: $6.44 billion
Sigma-Aldrich Corporation develops, manufactures, purchases and distributes a range of biochemicals and organic chemicals used in scientific and genomic research, biotechnology, and pharmaceutical development.
Stock price: $52.89
http://www.sigmaaldrich.com/

Smith & Nephew Plc (NYSE:SNN)
Market Cap: $8.14 billion
Smith & Nephew Plc develops, manufactures and markets medical devices for orthopedic reconstruction, orthopedic trauma and clinical therapies, endoscopy and advanced wound management.
Stock price: $46.01
http://www.smith-nephew.com/

$10-$20

Acorda Therapeutics, Inc. (NASDAQ:ACOR)
Market Cap: $936.76 million
Acorda Therapeutics, Inc. identifies, develops and commercializes therapies that improve neurological function in people with disorders of the central nervous system.
Stock price: $24.61
http://www.acorda.com/

Celera Corporation (NASDAQ:CRA)
Market Cap: $510.14 million
Celera Corporation delivers personalized disease management through a combination of products and services.
Stock price: $6.24
http://www.celera.com

Osiris Therapeutics Inc. (NASDAQ:OSIR)
Market Cap: $254.86 million
Osiris Therapeutics, Inc. develops and markets products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas.
Stock price: $7.78
http://www.osiristx.com/

Pfizer Inc. (NYSE:PFE)
Market Cap: $112.44 billion
Pfizer Inc. discovers, develops, manufactures and markets prescription medicines for humans and animals. It also operates several other businesses, including the manufacture of gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals.
Stock price: $16.66
http://www.pfizer.com

I urge you to sign up to our free email letter — you can do so right here…
to receive our free TFN eNews.

Read the rest of this TFN Research Report:


Next Article: Wal-Mart’s (NYSE:WMT) CEO resigns: Is trouble brewing?

Related Articles

Posted by J. Christoph Amberger · Filed Under Investment Research 

Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

 Add to Technorati Favorites | Follow Us on Twitter!

Be the first to leave a reply.

Your comments are welcome